Core Viewpoint - A class action lawsuit has been filed against Quantum Computing Inc. (QUBT) for allegedly misleading investors regarding its technology capabilities and business dealings, particularly with NASA and related party transactions [1][2]. Allegations - The lawsuit claims that QCI overstated its quantum computing technologies, its relationship with NASA, and the progress of its TFLN foundry [2]. - It is alleged that QCI's revenues were partially based on undisclosed related party transactions, which could significantly harm the company's reputation once revealed [2]. - A report by Capybara Research accused QCI of fabricating revenues and overstating ties to NASA, leading to a significant drop in stock price [3]. Stock Impact - Following the allegations, QCI's stock price fell by $1.72, or 14.89%, closing at $9.83 per share on January 17, 2025 [3]. Class Action Participation - Shareholders interested in participating as lead plaintiffs must file by April 28, 2025, but can remain absent class members without taking action [4]. Legal Representation - Robbins LLP operates on a contingency fee basis, meaning shareholders incur no fees or expenses unless the case is won [5].

Core Viewpoint - A class action has been filed against Zynex, Inc. for allegedly inflating its revenue and filing false claims, leading to significant financial repercussions for the company and its shareholders [1][2]. Group 1: Allegations and Financial Impact - The complaint alleges that Zynex shipped products in excess of need, resulting in inflated revenue [2]. - The company faced scrutiny from insurers, including Tricare, due to its practice of filing false claims [2]. - On March 11, 2025, Zynex reported a significant revenue shortfall attributed to slower payments from certain payers, leading to a 51.3% drop in stock price, closing at $3.41 per share [3]. Group 2: Class Action Participation - Shareholders may be eligible to participate in the class action against Zynex, with a deadline to file as lead plaintiff by May 19, 2025 [4]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [4]. Group 3: Company Background - Zynex, Inc. is a medical device manufacturer specializing in electrotherapy devices for pain management and physical rehabilitation [1].

SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of those who purchased or otherwise acquired Fluence Energy, Inc. (NASDAQ: FLNC) securities between November 29, 2023 and February 10, 2025. Fluence, through its subsidiaries, offers energy storage products and solutions, delivery services, recurring operational and maintenance services, and digital applications and solutions for energy storage and other power assets. For more information, ...

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who acquired ModivCare, Inc. (NASDAQ: MODV) securities between November 3, 2022, and September 15, 2024, alleging that the company misled investors regarding its business prospects [1][2]. Allegations - The complaint states that ModivCare failed to disclose that certain contracts in its Non-Emergency Medical Transportation (NEMT) segment led to a deterioration in the company's free cash flow [2]. - As a result of these undisclosed issues, the company experienced negative impacts on adjusted EBITDA due to contract renegotiations and pricing accommodations, and it faced liquidity challenges [2][3]. - The positive statements made by the company regarding its business operations and prospects were deemed materially misleading and lacked a reasonable basis [2][3]. Legal Proceedings - Shareholders interested in serving as lead plaintiffs in the class action must file necessary documents with the court by March 31, 2025 [4]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [4]. Company Background - Robbins LLP is recognized for its leadership in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [5].

Core Viewpoint - A class action lawsuit has been filed against The Trade Desk, Inc. for allegedly misleading investors about its business prospects during a specific period, particularly regarding the rollout of its new platform, Kokai [1][2]. Group 1: Allegations and Challenges - The lawsuit claims that The Trade Desk failed to disclose significant execution challenges related to the Kokai rollout, which included difficulties in transitioning clients from the older platform, Solimar [2]. - These execution challenges reportedly delayed the Kokai rollout and negatively impacted the company's business operations and revenue growth [2]. - The positive statements made by the company regarding its business and prospects were deemed materially false and misleading due to these undisclosed challenges [2]. Group 2: Financial Performance - On February 12, 2025, The Trade Desk reported fourth quarter revenue of $741 million, which was below its guidance of $756 million and analysts' estimates of $759.8 million [3]. - The company's revenue guidance for the first quarter of 2025 was at least $575 million, missing analysts' expectations of $581.5 million [3]. - Following the announcement of these results and the acknowledgment of the slower Kokai rollout, the stock price dropped by $40.31, or over 32%, from $122.23 to $81.92 per share [3].